US Patent 7919476 Modulation of glucagon receptor expression
Patent 7919476 was granted and assigned to Ionis Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7919476 Modulation of glucagon receptor expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
